Today, we are delighted to announce that there is to be a third funding match for the NAD+ Mouse Project!

Dr. David Sinclair will be personally matching the next $5000 in donations for the last 10 days of the campaign to help reach the final $60,000 goal. Now, that is what we call a devoted scientist!

If the project can reach this final fundraising goal, the project will greatly increase in scope and become a full-on lifespan study, including the collection of months of long-term data for NMN. This is the ultimate goal of the project and will allow the research team at Harvard Medical School to obtain enough NMN to be able to investigate a wide range of health measures as well as get a detailed picture of how long-term treatment with NMN affects the aging processes.

There is already a fair amount of data on the short-term use of NMN in mice and, shortly, humans. However, the one thing we currently lack are long-term studies for mice treated with NMN; this final goal will allow the research team to closely monitor the mice for up to two years, conduct many tests to assess healthspan and changes to physical and cognitive ability, and have an endpoint of recording any increase in maximum lifespan.

In addition, the data collected during the study will also help to inform human studies, some of which are currently underway at Harvard Medical School. Data from the ICE mice could provide fast initial results, and data from the normally aging mice could validate the human studies in the long term.

David Sinclair will also be answering questions today at 11 AM EDT in an Ask Me Anything on the Futurology subreddit. If you have questions about NMN or NAD+ biology or are curious about his research in general, today is the chance to ask him anything.

Could NMN be a true longevity pill? You have the opportunity to help us find out. Visit the NAD+ Mouse Project today, and help us reach the final goal!

About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:


Your email address will not be published.

Privacy Policy / Terms Of Use

       Powered by MMD